$GPUS
Hyperscale Data, Inc. Stock $gpus

$gpus Overview Financials Valuation SEC Filings Company Website

2017 Q1 Form 10-Q Financial Statement

#000143774917009425 Filed on May 17, 2017

Income Statement

Concept	2017 Q1	2016 Q4	2016 Q1
Revenue	$1.628M	$1.990M	$1.713M
YoY Change	-4.96%	-13.48%	-9.65%
Cost Of Revenue	$920.0K	$1.360M	$1.093M
YoY Change	-15.83%	-14.47%	-7.61%
Gross Profit	$708.0K	$630.0K	$620.0K
YoY Change	14.19%	-12.5%	-13.04%
Gross Profit Margin	43.49%	31.66%	36.19%
Selling, General & Admin	$1.268M	$1.380M	$626.0K
YoY Change	102.56%	94.37%	-10.32%
% of Gross Profit	179.1%	219.05%	100.97%
Research & Development	$227.0K	$200.0K	$194.0K
YoY Change	17.01%	-13.04%	-17.09%
% of Gross Profit	32.06%	31.75%	31.29%
Depreciation & Amortization	$33.00K	$40.00K	$40.00K
YoY Change	-17.5%	0.0%	-31.03%
% of Gross Profit	4.66%	6.35%	6.45%
Operating Expenses	$1.495M	$1.580M	$820.0K
YoY Change	82.32%	68.09%	-12.02%
Operating Profit	-$787.0K	-$950.0K	-$200.0K
YoY Change	293.5%	331.82%	-8.68%
Interest Expense	-$207.0K		$7.000K
YoY Change	-3057.14%		-90.0%
% of Operating Profit
Other Income/Expense, Net	-$207.0K	-$10.00K	$7.000K
YoY Change	-3057.14%		-89.23%
Pretax Income	-$990.0K	-$960.0K	-$193.0K
YoY Change	412.95%	317.39%	-5.39%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$994.0K	-$960.0K	-$193.0K
YoY Change	415.03%	317.39%	-5.39%
Net Earnings / Revenue	-61.06%	-48.24%	-11.27%
Basic Earnings Per Share
Diluted Earnings Per Share	-$28.49K	-$31.32K	-$6.843K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q1	2016 Q4	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.100M	$1.000M	$1.200M
YoY Change	-8.33%	-16.67%	-42.86%
Cash & Equivalents	$1.138M	$996.0K	$1.158M
Short-Term Investments
Other Short-Term Assets	$300.0K	$300.0K	$200.0K
YoY Change	50.0%	50.0%	0.0%
Inventory	$937.0K	$1.122M	$1.428M
Prepaid Expenses
Receivables	$1.030M	$1.439M	$1.261M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$3.377M	$3.842M	$4.095M
YoY Change	-17.53%	-10.38%	-21.25%
LONG-TERM ASSETS
Property, Plant & Equipment	$543.0K	$570.0K	$729.0K
YoY Change	-25.51%	-19.61%	21.5%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.700M	$1.000M	$100.0K
YoY Change	1600.0%	900.0%	-50.0%
Other Assets	$100.0K	$0.00	$0.00
YoY Change
Total Long-Term Assets	$2.328M	$1.630M	$832.0K
YoY Change	179.81%	100.74%	-1.89%
TOTAL ASSETS
Total Short-Term Assets	$3.377M	$3.842M	$4.095M
Total Long-Term Assets	$2.328M	$1.630M	$832.0K
Total Assets	$5.705M	$5.472M	$4.927M
YoY Change	15.79%	7.32%	-18.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$896.0K	$1.231M	$1.013M
YoY Change	-11.55%	31.38%	12.56%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$500.0K	$300.0K
YoY Change
Total Short-Term Liabilities	$1.842M	$1.879M	$1.663M
YoY Change	10.76%	15.42%	-12.47%
LONG-TERM LIABILITIES
Long-Term Debt	$100.0K	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$100.0K	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.842M	$1.879M	$1.663M
Total Long-Term Liabilities	$100.0K	$0.00	$0.00
Total Liabilities	$1.920M	$1.913M	$1.700M
YoY Change	12.94%	17.51%	-10.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$13.15M	-$12.16M	-$11.23M
YoY Change	17.13%	10.17%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.785M	$3.559M	$3.264M
YoY Change
Total Liabilities & Shareholders Equity	$5.705M	$5.472M	$4.927M
YoY Change	15.79%	7.32%	-17.88%

Cashflow Statement

Concept	2017 Q1	2016 Q4	2016 Q1
OPERATING ACTIVITIES
Net Income	-$994.0K	-$960.0K	-$193.0K
YoY Change	415.03%	317.39%	-5.39%
Depreciation, Depletion And Amortization	$33.00K	$40.00K	$40.00K
YoY Change	-17.5%	0.0%	-31.03%
Cash From Operating Activities	-$270.0K	-$500.0K	$8.000K
YoY Change	-3475.0%	-814.29%	-93.16%
INVESTING ACTIVITIES
Capital Expenditures	$3.000K	$10.00K	$72.00K
YoY Change	-95.83%	-94.44%	-27.27%
Acquisitions
YoY Change
Other Investing Activities	-$690.0K	-$1.030M	$0.00
YoY Change
Cash From Investing Activities	-$690.0K	-$1.040M	-$72.00K
YoY Change	858.33%	477.78%	-27.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$300.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.100M	1.280M	0.000
YoY Change
NET CHANGE
Cash From Operating Activities	-270.0K	-500.0K	8.000K
Cash From Investing Activities	-690.0K	-1.040M	-72.00K
Cash From Financing Activities	1.100M	1.280M	0.000
Net Change In Cash	140.0K	-260.0K	-64.00K
YoY Change	-318.75%	136.36%	-455.56%
FREE CASH FLOW
Cash From Operating Activities	-$270.0K	-$500.0K	$8.000K
Capital Expenditures	$3.000K	$10.00K	$72.00K
Free Cash Flow	-$273.0K	-$510.0K	-$64.00K
YoY Change	326.56%	363.64%	-455.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2016	dpw	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice	0.67
CY2017Q1	dpw	Accretion Of Discount On Note Receivable AccretionOfDiscountOnNoteReceivable	-7000
CY2016Q1	dpw	Accretion Of Discount On Note Receivable AccretionOfDiscountOnNoteReceivable
CY2017Q1	dpw	Availableforsale Securities Original Issue Discount AvailableforsaleSecuritiesOriginalIssueDiscount	68000
CY2016Q4	dpw	Availableforsale Securities Original Issue Discount AvailableforsaleSecuritiesOriginalIssueDiscount	45000
CY2017Q1	dpw	Cancellation Of Convertible Securities Exercise Price Of Convertible Securities CancellationOfConvertibleSecuritiesExercisePriceOfConvertibleSecurities	0.60
CY2017Q1	dpw	Cancellation Of Convertible Securities Number Of Securities Called By Convertible Securities CancellationOfConvertibleSecuritiesNumberOfSecuritiesCalledByConvertibleSecurities	666667
CY2017Q1	dpw	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	39682
CY2017Q1	dpw	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Warrants Exercisable ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsWarrantsExercisable	0.01
CY2017Q1	dpw	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	690476
CY2016	dpw	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	1749126
CY2016Q4	dpw	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	1749126
CY2017Q1	dpw	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice	0.7
CY2016Q4	dpw	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice	0.67
CY2017Q1	dpw	Class Of Warrant Or Right Term ClassOfWarrantOrRightTerm	P5Y
CY2016Q4	dpw	Debt Discount DebtDiscount	518000
CY2016Q4	dpw	Debt Discount Beneficiary Conversion Feature DebtDiscountBeneficiaryConversionFeature	329000
CY2016Q4	dpw	Debt Discount Original Issue Discount DebtDiscountOriginalIssueDiscount	30000
CY2016Q4	dpw	Debt Discount Warrant DebtDiscountWarrant	159000
CY2016Q4	dpw	Debt Instrument Compel To Convert Option Minimum Share Price DebtInstrumentCompelToConvertOptionMinimumSharePrice	3
CY2017Q1	dpw	Elimination For Intersegment Revenues EliminationForIntersegmentRevenues
CY2016Q1	dpw	Elimination For Intersegment Revenues EliminationForIntersegmentRevenues
CY2017Q1	dpw	Interest Expense Due To Conversion Of Debt InterestExpenseDueToConversionOfDebt	13000
CY2017Q1	dpw	Interest Expense Due To Conversion Of Debt InterestExpenseDueToConversionOfDebt	13000
CY2016Q1	dpw	Interest Expense Due To Conversion Of Debt InterestExpenseDueToConversionOfDebt
CY2017Q1	dpw	Proceeds From Loans Investing Activity ProceedsFromLoansInvestingActivity	-59000
CY2016Q1	dpw	Proceeds From Loans Investing Activity ProceedsFromLoansInvestingActivity
CY2017Q1	dpw	Proceeds From Sale Of Common Stock And Warrants ProceedsFromSaleOfCommonStockAndWarrants	300000
CY2016Q1	dpw	Proceeds From Sale Of Common Stock And Warrants ProceedsFromSaleOfCommonStockAndWarrants
CY2017Q1	dpw	Revenues Excluding Intersegment Revenue RevenuesExcludingIntersegmentRevenue	1628000
CY2016Q1	dpw	Revenues Excluding Intersegment Revenue RevenuesExcludingIntersegmentRevenue	1713000
CY2017Q1	dpw	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Weighted Average Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue	0.45
CY2016Q4	dpw	Warrant Exercisable Term WarrantExercisableTerm	P180D
CY2016Q4	dpw	Warrant Force Redemption Price WarrantForceRedemptionPrice	0.001
CY2017Q1	dpw	Warrant Term WarrantTerm	P4Y87D
CY2017Q1	dpw	Working Capital WorkingCapital	1535000
CY2017Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	896000
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1231000
CY2017Q1	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	28000
CY2016Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent
CY2017Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1030000
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1439000
CY2017Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-799000
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-820000
CY2017Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	17736000
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	16537000
CY2016Q4	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	159000
CY2017Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	124000
CY2016Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	44000
CY2017Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	195000
CY2016Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0
CY2017Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	195000
CY2016Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts
CY2017Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6208921
CY2016Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1106000
CY2017Q1	us-gaap	Assets Assets	5705000
CY2016Q4	us-gaap	Assets Assets	5472000
CY2016Q1	us-gaap	Assets Assets	4927000
CY2017Q1	us-gaap	Assets Current AssetsCurrent	3377000
CY2016Q4	us-gaap	Assets Current AssetsCurrent	3842000
CY2017Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1653000
CY2016Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1036000
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1138000
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	996000
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8856853
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7677637
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8856853
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7677637
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1241000
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1158000
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	142000
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-83000
CY2017Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.70
CY2017Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.68
CY2017Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	333333
CY2017Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	357143
CY2016Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	530000
CY2017Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2439602
CY2017Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2017Q1	us-gaap	Common Stock Value CommonStockValue
CY2016Q4	us-gaap	Common Stock Value CommonStockValue
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-973000
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-251000
CY2017Q1	us-gaap	Convertible Debt ConvertibleDebt	530000
CY2016Q4	us-gaap	Convertible Debt ConvertibleDebt	530000
CY2017Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	78000
CY2016Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	34000
CY2017Q1	us-gaap	Cost Of Revenue CostOfRevenue	920000
CY2016Q1	us-gaap	Cost Of Revenue CostOfRevenue	1093000
CY2017Q1	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	400000
CY2016Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.55
CY2017Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	400000
CY2017Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.06
CY2017Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	151000
CY2017Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	441000
CY2016Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	484000
CY2017Q1	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	453000
CY2016Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	497000
CY2016Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	13000
CY2017Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	11000
CY2016Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	12000
CY2017Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	112000
CY2016Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	24000
CY2017Q1	us-gaap	Depreciation Depreciation	33000
CY2016Q1	us-gaap	Depreciation Depreciation	40000
CY2017Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	33000
CY2016Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	40000
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.12
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03
CY2017Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	9000
CY2016Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-19000
CY2017Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	190000
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	128000
CY2017Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	973000
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	371000
CY2017Q1	us-gaap	Gross Profit GrossProfit	708000
CY2016Q1	us-gaap	Gross Profit GrossProfit	620000
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-338000
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	66000
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	28000
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	10000
CY2017Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-413000
CY2016Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	32000
CY2017Q1	us-gaap	Increase Decrease In Deferred Revenue And Customer Advances And Deposits IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
CY2017Q1	us-gaap	Liabilities Liabilities	1920000
CY2016Q4	us-gaap	Liabilities Liabilities	1913000
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5705000
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5472000
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1842000
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1879000
CY2016Q1	us-gaap	Increase Decrease In Deferred Revenue And Customer Advances And Deposits IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits	-93000
CY2017Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-193000
CY2016Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-87000
CY2017Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	29000
CY2016Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0
CY2017Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	49000
CY2016Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	66000
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-15000
CY2016Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-13000
CY2017Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	44000
CY2017Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-207000
CY2016Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	7000
CY2017Q1	us-gaap	Interest Paid InterestPaid	12000
CY2016Q1	us-gaap	Interest Paid InterestPaid
CY2017Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	16000
CY2016Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	12000
CY2017Q1	us-gaap	Inventory Net InventoryNet	937000
CY2016Q4	us-gaap	Inventory Net InventoryNet	1122000
CY2017Q1	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	20000
CY2016Q4	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1097000
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-692000
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-72000
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-272000
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	8000
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-994000
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-193000
CY2017Q1	us-gaap	Notes Payable Current NotesPayableCurrent	220000
CY2016Q4	us-gaap	Notes Payable Current NotesPayableCurrent
CY2017Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	250000
CY2016Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	250000
CY2017Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	1495000
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	820000
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-787000
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-200000
CY2017Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	20000
CY2016Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3000
CY2016Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	72000
CY2017Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2017Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	171000
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	184000
CY2017Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	21000
CY2016Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-58000
CY2017Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	21000
CY2016Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-58000
CY2017Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	448000
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	398000
CY2017Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-207000
CY2016Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7000
CY2017Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	73000
CY2016Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts
CY2017Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	610000
CY2016Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2017Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2017Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2017Q1	us-gaap	Preferred Stock Value PreferredStockValue
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2017Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	272000
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	285000
CY2016Q4	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	500000
CY2017Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	300000
CY2017Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	350000
CY2016Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt
CY2017Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	520000
CY2016Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable
CY2017Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	86000
CY2016Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	86000
CY2017Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	543000
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	570000
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	227000
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	194000
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13152000
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12158000
CY2017Q1	us-gaap	Revenues Revenues	1628000
CY2016Q1	us-gaap	Revenues Revenues	1713000
CY2017Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.60
CY2017Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	0.86
CY2017Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	295000
CY2016Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	255000
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	157000
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	44000
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.985
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.984
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0214
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0189
CY2017Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1515167
CY2017Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	2766000
CY2017Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
CY2017Q1	us-gaap	Share Price SharePrice	0.84
CY2017Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2017Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	0.79
CY2017Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P8Y200D
CY2017Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	500000
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	3785000
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	3559000
CY2017Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Accounting Estimates</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of financial statements, in conformity with GAAP, requires management to make estimates, judgments and assumptions. The Company's management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates. Key estimates include fair value of certain financial instruments, reserve for trade receivables and inventories, carrying amounts of investments, accruals of certain liabilities, and deferred income taxes and related valuation allowance.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2017Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8383000
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6776000

Files In Submission

Name	View Source	Status
0001437749-17-009425-index-headers.html	Edgar Link	pending
0001437749-17-009425-index.html	Edgar Link	pending
0001437749-17-009425.txt	Edgar Link	pending
0001437749-17-009425-xbrl.zip	Edgar Link	pending
dpw-20170331.xml	Edgar Link	completed
dpw-20170331.xsd	Edgar Link	pending
dpw-20170331_cal.xml	Edgar Link	unprocessable
dpw-20170331_def.xml	Edgar Link	unprocessable
dpw-20170331_lab.xml	Edgar Link	unprocessable
dpw-20170331_pre.xml	Edgar Link	unprocessable
dpw20170331_10q.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GPUS
Hyperscale Data, Inc. Stock $gpus

2017 Q1 Form 10-Q Financial Statement

#000143774917009425 Filed on May 17, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GPUS Hyperscale Data, Inc. Stock $gpus

2017 Q1 Form 10-Q Financial Statement

#000143774917009425 Filed on May 17, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GPUS
Hyperscale Data, Inc. Stock $gpus